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Abstract The myelin-associated glycoprotein (MAG) has been
proposed to be important for the integrity of myelinated axons.
For a better understanding of the interactions involved in the
binding of MAG to neuronal axons, we performed this study to
identify the binding partners for MAG on neuronal cells.
Experiments with glycosylation inhibitors revealed that sialy-
lated N-glycans of glycoproteins represent the major binding
sites for MAG on the neuroblastoma cell line N2A. From
extracts of [3H]glucosamine-labelled N2A cells several glyco-
proteins with molecular weights between 20 and 230 kDa were
affinity-precipitated using immobilised MAG. The interactions
of these proteins with MAG were sialic acid-dependent and
specific for MAG.
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1. Introduction
The myelin-associated glycoprotein (MAG) is a 100-kDa
integral membrane glycoprotein expressed by myelinating
glia cells in the central and peripheral nervous system [1]. It
consists of ¢ve extracellular immunoglobulin-like (Ig-like) do-
mains with 8^9 potential glycosylation sites, and a carboxy-
terminal intracellular domain with several phosphorylation
sites [2]. Structurally most closely related proteins are the
Schwann cell myelin protein (SMP), sialoadhesin (Sn),
CD22 and CD33, which all bind to sialic acid (Sia)-containing
cell surface glycoconjugates [3,4]. Based on this speci¢city and
some unique structural features, the name siglecs has been
proposed for this group of Ig-like proteins [5].
For MAG, several functions in interactions between glia
cells and neurones have been proposed [6^8]. Whereas in vitro
experiments provided evidence that MAG is important for the
initiation of myelination during development [9], myelination
of axons occurs also in mice in which the MAG gene had been
disrupted (MAG3=3 mice) [10,11]. However, several abnor-
malities were observed in the morphology of myelinated axons
in these animals. Animals older than 8 months show increased
signs of a disturbed maintenance of their axon-myelin units
indicating that MAG plays a role in long-term maintenance of
the integrity of both myelin and axons [12,13].
An interesting aspect of MAG is its in£uence on neuronal
growth. In vitro, MAG promotes neurite outgrowth of em-
bryonal dorsal root ganglion neurones [14^16], whereas it in-
hibits the neurite outgrowth of cerebellar neurones, adult dor-
sal root ganglion neurones [15] and neuroblastoma cells [17].
The role of MAG as a neurone regeneration inhibiting
molecule in vivo has remained controversial [6,7] since ¢rst
experiments with MAG3=3 mice gave no clear evidence for a
signi¢cant contribution of MAG [18,19]. However, improved
axonal regrowth has been demonstrated in MAG3=3 mice
cross-bred with animals of the strain C57BL/Wlds that have
delayed lesion-induced myelin degradation and axonal re-
growth in the peripheral nervous system [20], indicating a
signi¢cant inhibitory e¡ect of MAG on neurone regeneration
processes also in vivo.
Although the role of MAG as a cell adhesion molecule has
been under investigation for many years, and binding activ-
ities to various extracellular components have been reported
[21,22], no neuronal binding partners for MAG have been
characterised so far. First evidence for Sia-containing glyco-
conjugates as binding partners for MAG came from the ob-
servation that MAG binds to sialylated glycans on erythro-
cytes [23]. The speci¢city of MAG for such glycans has been
investigated in detail using gangliosides [24^26] or synthetic
sialylated mono- and oligosaccharides [27,28]. Whereas ex-
periments with resialylated red blood cells suggested that
MAG binds preferentially to Neu5Aca2,3GalL1,3GalNAc, a
structure typically found on O-glycans of glycoproteins and
on gangliosides [23], a direct comparison of free monovalent
oligosaccharides in hapten inhibition assays revealed that
structures found on N-glycans, i.e. Neu5Aca2,3GalL1,3Glc-
NAc and Neu5Aca2,3GalL1,4GlcNAc, were at least as well
recognised as Neu5Aca2,3GalL1,3GalNAc [28].
The functions of MAG mentioned above are likely to in-
volve binding partners (counter-receptors) on neuronal cells.
Although it is known that MAG binding is mediated by sia-
lylated glycans, it has remained unclear by which structures,
e.g. glycoproteins and/or glycolipids, these glycans are pre-
sented. Speci¢c binding to gangliosides has been clearly dem-
onstrated [23,24,26]. However, MAG binding to neuronal
cells may be mainly to glycoproteins, since it is trypsin-sensi-
tive [16]. The aim of this study has been the isolation of bind-
ing partners for MAG from the neuroblastoma cell line N2A.
2. Materials and methods
2.1. Reagents
A⁄nity-puri¢ed anti-human IgG antibodies were from BiÖdesign,
Kennebunk, ME, USA; carrier-free Na125I was from Amersham,
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Braunschweig, Germany; protein A beads were from Pharmacia Bio-
tech, Uppsala, Sweden; sialidase from Vibrio cholerae was purchased
from Behringwerke, Marburg, Germany.
2.2. Fc chimeras
Plasmids encoding the Fc chimeras containing the N-terminal three
domains of MAG (Fc-MAGd1ÿ3) or the N-terminal ¢ve domains of
MAG (Fc-MAGd1ÿ5 [23], the N-terminal domain of sialoadhesin (Sn)
(Fc-Snd1) [29] or the N-terminal three domains of murine CD22 (Fc-
CD22d1ÿ3) [23] have been described. Fc chimeras were produced by
transient expression of the plasmid in COS cells followed by puri¢ca-
tion from the tissue culture supernatants by immunoa⁄nity chro-
matography on protein A agarose [30]. Fc chimeras containing the
N-terminal part of NCAM [31] were a kind gift from Dr Paul R.
Crocker.
2.3. Binding assays
Puri¢ed Fc-MAG was labelled with 125I and complexed with equi-
molar concentration of anti-human IgG to be used in binding assays
as described [23,30,32].
2.3.1. Binding to adherent cells
Cells were grown on 10-mm coverslips, washed with phosphate-
bu¡ered saline (PBS) and ¢xed with 0.25% glutardialdehyde in PBS
for 10 min at room temperature [33]. 200 Wl radio-iodinated Fc-MAG/
anti-human IgG complex was added to the cells, which were incu-
bated overnight at 4‡C. Unbound radioactivity was removed by dip-
ping the coverslips three times in PBS containing 0.25% bovine serum
albumin. Bound radioactivity was quanti¢ed by gamma counting. As
a control for Sia speci¢city, binding to sialidase-treated cells was
estimated.
2.3.2. Binding to cells in suspension
Adherent cells were detached from the cell culture plates with PBS
containing 10 mM EDTA and 0.02% azide and ¢xed as described
above. 25 Wl radio-iodinated Fc-MAG/anti-human IgG complex was
mixed with 25 Wl cell suspension. After overnight incubation at 4‡C
bound radioactivity was quanti¢ed as described [30]. As a control for
Sia speci¢city, binding to sialidase-treated cells was estimated and
subtracted as background.
2.3.3. Elution of cell bound Fc-MAG/anti human
IgG-complexes with a2,3-sialyllactose (a2,3SL)
Fc-MAG/anti-human IgG complexes were allowed to bind to cells
in suspension and unbound radioactivity was removed by washing the
cells. 20 Wl a2,3SL at di¡erent concentrations was added to the cells
and the mixture was incubated for 30 min at 4‡C. The amounts of
radioactivity remaining on the cells and in the supernatants were
quanti¢ed by gamma counting. As a control for Sia speci¢city, bind-
ing to sialidase-treated cells was estimated and subtracted as back-
ground.
2.4. Glycosylation inhibition
N2A cells were cultured for 3 days in the presence of 5 mM benzyl-
N-acetyl-a-D-galactosamine (benzyl-GalNAc) for the inhibition of
O-glycosylation or in the presence of 10 WM swainsonine to inhibit
the processing of N-glycans.
2.5. [3H]Glucosamine-labelled N2A cell extracts
70% con£uent N2A cells were trypsinised in order to destroy MAG
ligands on these cells, transferred to a new 100-mm cell culture dish at
the same density and incubated in 6.6 ml DMEM containing 200 mM
glutamine, 37.5 Wl foetal bovine serum (FBS), 375 Wl dialysed FBS
and 20 MBq D-[6-3H]glucosamine hydrochloride for at least 3 days.
After labelling cells were washed with PBS and lysed with 1 ml 20 mM
Tris pH 7.5 containing 150 mM NaCl, 5 mM EDTA, 1% NP-40 (lysis
bu¡er) and the following protease inhibitors: 1.5 mM PMSF, 0.5 Wg/
ml leupeptin and 0.2 Wg/ml trasylol. Insoluble material was removed
by centrifugation for 15 min at 3500 min31.
2.6. A⁄nity precipitation of MAG binding partners
35 Wg Fc chimeras were incubated for 1 h with 10 Wl protein A
beads at room temperature and unbound Fc chimeras were removed
by three washes with 1 ml lysis bu¡er. 1 ml 3H-GlcNAc-labelled N2A
cell extract was preincubated with 10 Wl protein A beads for 1 h at
4‡C, centrifuged and the supernatant was mixed with Fc-MAG-
loaded protein A beads. After overnight incubation at 4‡C under
gentle shaking, the beads were centrifuged and washed four times
with lysis bu¡er containing 0.1% NP-40. Bound proteins were eluted
from the beads by boiling for 5 min in the presence of 20 Wl of SDS-
PAGE sample bu¡er.
2.7. SDS-PAGE and Western blotting
SDS-PAGE was performed according to Laemmli using 10% or 8%
polyacrylamide gels. For Western blot analysis proteins were trans-
ferred to nitrocellulose and detected by autoradiography or by phos-
phor imaging.
3. Results
For the isolation of neuronal binding partners of MAG a
suitable source had to be found. Since neurones from primary
tissue culture are only available in limited amounts, several
cell lines were compared for binding of MAG (Fig. 1). For all
cell types, binding was Sia-dependent, since sialidase treat-
ment of the cells reduced the amount of bound Fc-MAG to
background levels. MAG showed high binding to the murine
neuroblastoma cell line N2A, whereas binding to PC12, C6,
L929 and S-16 cells was signi¢cantly lower. Therefore, N2A
cells were chosen for the isolation of counter-receptors for
MAG.
Up to now it has not been clear whether natural counter-
receptors for MAG are glycoproteins and/or glycolipids. In
order to investigate whether N- and/or O-glycans on glyco-
proteins are responsible for MAG binding to N2A cells, these
cells were cultivated in the presence of swainsonine, which
prevents processing of N-glycans by inhibiting the Golgi man-
nosidase II [34], or the O-glycosylation inhibitor benzyl-Gal-
NAc, which inhibits competitively the extension of GalNAca-
Ser/Thr on glycoproteins [35]. The e¡ect of glycosylation in-
hibitors was checked by FACS-analysis with £uorescein-la-
belled lectins (data not shown). Binding of PNA to siali-
dase-treated cells revealed that O-glycosylation was reduced
by benzyl-GalNAc but not by swainsonine. On the other
hand, swainsonine-treated cells showed higher binding of con-
canavalin A (Con A) than untreated cells indicating that more
accessible mannose residues were presented on these cells.
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Fig. 1. Sialic acid-dependent binding of Fc-MAGd1ÿ3 to di¡erent
cell lines. Cells were grown on coverslips and ¢xed with glutardial-
dehyde. Binding of radio-iodinated antibody-complexed Fc-MAG to
native and sialidase-treated cells was estimated as described in Sec-
tion 2. N2A = neuroblastoma cells, PC12 = cells from an rat adrenal
phaeochromocytoma, C6 = rat glioma cells, L929 = mouse ¢broblasts
and S-16 = Schwann cell line.
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Furthermore, the lectin staining demonstrated that the overall
cell surface expression of N- or O-glycosylated proteins was
not disturbed by swainsonine. If assayed for Sia-dependent
MAG binding, swainsonine-treated N2A cells did not bind
Fc-MAG above background levels, whereas benzyl-GalNAc
treatment apparently did not signi¢cantly in£uence MAG
binding (Fig. 2). This is strong evidence that the majority if
not all of the MAG binding sites are complex N-glycans on
glycoproteins.
Therefore, MAG counter-receptors were puri¢ed from pro-
tein extracts of N2A cells by a⁄nity precipitation with Fc-
MAG bound to protein A agarose. First, molecules which
bind to protein A beads independent of MAG were removed
by preincubation of the cell extract with protein A beads in
the absence of Fc-MAG. In order to allow easy detection of
neuronal glycoproteins after isolation N2A cells were meta-
bolically labelled with 3H-GlcNAc. Since the a⁄nity of MAG
to a single glycan is relatively low, a high density of Fc-MAG
bound to protein A beads was used for the precipitation in
order to allow polyvalent interactions. Less than 5% of the
radioactivity incorporated into the cells was precipitated with
Fc-MAG-loaded protein A beads. The autoradiograph of
proteins a⁄nity-precipitated with MAG revealed several
somewhat di¡use bands typical for glycoproteins (Fig. 3A,
lane 2). The apparent molecular masses are between 20 and
130 kDa. The broad band above 116 kDa (Fig. 3A, lane 2)
appears to be a double band of two proteins with molecular
weights about 116 and 130 kDa, if proteins are separated on
8% polyacrylamide gels (Fig. 4A,C). In addition, glycopro-
teins with molecular masses of 180 and 230 kDa were precipi-
tated. However, these were only detected by the more sensitive
phosphor imaging technique (Fig. 4A,C), whereas they were
hardly visible on autoradiographs (Fig. 3A, lane 2). Since the
lysis of N2A cells was performed in the presence of protease
inhibitors and the pattern of glycoproteins precipitated was
reproducible in several independent experiments, it is unlikely
that the bands are the products of proteolytic cleavage.
The next question was whether these glycoproteins interact
speci¢cally with MAG or whether they also bind to other cell
interaction molecules. Therefore, the same a⁄nity puri¢cation
was performed with Fc-NCAM (Fig. 3A, lane 3), Fc-CD22
(Fig. 3A, lane 4) or Fc-Sn (Fig. 3B, lane 2) instead of Fc-
MAG. In these experiments several proteins were precipitated,
but they were di¡erent from those obtained with Fc-MAG,
even if Fc-Sn was used, a siglec which has a glycan speci¢city
similar to MAG. This indicates that the isolated glycoproteins
bind MAG with high speci¢city. It is important to note that
di¡erences in the pattern of bands precipitated with Fc-MAG
(Fig. 3A, lane 1 vs Fig. 3B, lane 1) are due to di¡erent per-
centages of polyacrylamide used for SDS-PAGE. Because of a
better resolution at high molecular weights 8% polyacrylamide
gels were used in all subsequent experiments.
The Sia dependence of the a⁄nity precipitation has been
shown by sialidase treatment of 3H-GlcNAc-labelled N2A
cells before lysis. Only three bands were detectable in the
extracts of sialidase-treated cells (Fig. 4A, lane 2). However,
the intensities of these bands were much lower than those
from parallel precipitations of extracts from untreated cells
indicating that also these molecules were bound in a Sia-de-
pendent manner. The same results were obtained if the Fc-
MAG/protein A beads were preincubated with 10 mM a2,3SL
as inhibitor for Sia-dependent binding (Fig. 4A, lane 3).
To investigate whether binding of MAG to its binding part-
ners is reversible by the addition of competitive inhibitors,
N2A cells with bound radio-iodinated Fc-MAG/anti-human
IgG complexes were incubated with di¡erent concentrations
of a2,3SL as competitive inhibitor for the Sia binding site on
MAG. Depending on the a2,3SL concentration the cell-bound
radioactivity decreased, corresponding to an increase of radio-
activity in the supernatant (Fig. 4B). Almost complete elution
was obtained at an a2,3SL concentration of 50 mM, whereas
no radioactivity was eluted by PBS (data not shown). These
results indicate that counter-receptors can be eluted from
MAG by suitable competitive inhibitors.
Taking advantage of this ¢nding, a2,3SL was applied for
the elution of MAG counter-receptors bound to the Fc-MAG/
protein A beads as a further puri¢cation step. Some of the
precipitated glycoproteins were eluted by incubation with 100
mM a2,3SL whereas no proteins could be eluted with PBS
(Fig. 4C). The band pattern in this experiment seems to be
somewhat di¡erent especially for bands in the 100^150-kDa
range. This is due to aberrant running behaviour of samples
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Fig. 3. SDS-PAGE of a⁄nity-precipitated glycoproteins from N2A
cells with di¡erent adhesion molecules. A⁄nity precipitations of
binding partners for di¡erent cell interaction molecules from ex-
tracts of [3H]glucosamine-labelled N2A cells were performed as de-
scribed Section 2. A: Samples were analysed by SDS-PAGE on a
10% polyacrylamide gel. Lane 1: 10 Wl of total cell extract; lane 2:
glycoproteins from a⁄nity precipitations with Fc-MAGd1ÿ3 ; lane 3:
glycoproteins from a⁄nity precipitation with Fc-NCAMd1ÿ5 ; lane
4: glycoproteins from a⁄nity precipitation with Fc-CD22d1ÿ3. Mo-
lecular weight markers are shown on the left. B: Samples were ana-
lysed by SDS-PAGE on an 8% polyacrylamide gel. Lane 1: glyco-
proteins from a⁄nity precipitations with Fc-MAGd1ÿ5 ; lane 2:
glycoproteins from a⁄nity precipitation with Fc-Snd1. Molecular
weight markers are shown on the right.
Fig. 2. In£uence of glycosylation inhibitors on the Sia-dependent
binding of Fc-MAG to N2A cells. N2A cells were grown for 3 days
in the presence of the glycosylation inhibitors indicated and Sia-spe-
ci¢c binding of radio-iodinated antibody-complexed Fc-MAG to
2.5U104, 5U104 and 10U104 of these cells or to control cells was
estimated as described in Section 2.
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from a⁄nity precipitations as a result of large amounts of
unlabelled Fc-MAG in these lanes.
4. Discussion
Various roles for MAG have been proposed in myelin/axon
interactions. For a better understanding of these processes the
neuronal binding partners of MAG have to be identi¢ed and
characterised. In choosing a suitable source for MAG ligands
several problems have to be considered. For a biochemical
characterisation of the isolated molecules su⁄cient amounts
are necessary, which may not be easy to obtain from freshly
isolated neurones or primary cell cultures. Furthermore, it has
to be kept in mind that in vivo neurones from di¡erent areas
and stages of development do not necessarily carry the same
counter-receptors for MAG. Therefore, we decided to use a
cell line which can be obtained in large amounts. In addition,
such cell lines allow easy metabolic labelling of glycoconju-
gates for a more sensitive detection. Since also a neuroblasto-
ma cell line was used for studies showing MAG inhibition of
neurite outgrowth [17], it is likely that molecules which are
relevant for MAG-mediated signalling also occur on neuro-
blastoma cell lines. N2A cells were used, since they showed
high Sia-dependent binding of MAG (Fig. 1), indicating that
possibly su⁄cient amounts of counter-receptors for MAG are
expressed by these cells. Of course it remains uncertain
whether these represent the same molecules expressed by neu-
rones in vivo. First experiments with neurones from primary
cell culture indicate that this is indeed the case (data not
shown). Future studies will address this question.
Counter-receptors for MAG could be glycoproteins or gly-
colipids. In vitro MAG can bind to both [23^26]. The ¢nding
that MAG binding is trypsin-sensitive [16] has indicated that
ligands for MAG are mainly glycoproteins. This is strongly
supported by our ¢nding that N2A cells grown in the presence
of the N-glycosylation inhibitor swainsonine loose their ability
to bind MAG (Fig. 2). This ¢nding implies that glycoproteins
and not glycolipids are the main structures recognised by
MAG on these cells. Swainsonine inhibits the processing of
N-glycans of glycoproteins, whereas other types of glycans
such as O-glycans on glycoproteins or glycolipids are not
a¡ected [34]. In spite of its e¡ect on oligosaccharide biosyn-
thesis, swainsonine seems not to impair the cell surface ex-
pression of incompletely processed glycoproteins [36] as dem-
onstrated by the lectin staining experiments. In addition,
inhibition of O-glycosylation by benzyl-GalNAc did not sig-
ni¢cantly in£uence binding of MAG to these cells (Fig. 2),
strongly suggesting that O-glycans do not contribute to a
large extent to MAG binding in this system. In hapten in-
hibition assays with synthetic oligosaccharides it has been
demonstrated that the terminal sequences Neu5Aca2,3-
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Fig. 4. Sialic acid dependence of a⁄nity precipitations with Fc-
MAGd1ÿ3 from [3H]glucosamine-labelled N2A cell extract. A: SDS-
PAGE of a⁄nity precipitations with [3H]glucosamine-labelled N2A
cell extract. A⁄nity precipitations of ligands for Fc-MAGd1ÿ3 from
[3H]glucosamine-labelled N2A cell extracts were performed as de-
scribed in Section 2. Lane 1: glycoproteins from a⁄nity precipita-
tion with Fc-MAGd1ÿ3 ; lane 2: glycoproteins from a⁄nity precipi-
tation with Fc-MAGd1ÿ3 of extract from VCS-treated
[3H]glucosamine-labelled N2A cells; lane 3: glycoproteins from a⁄n-
ity precipitation with Fc-MAGd1ÿ3 preincubated with 10 mM
a2,3SL. Molecular weights are indicated on the left. B: Elution of
prebound Fc-MAG from N2A cells. Radio-iodinated antibody-com-
plexed Fc-MAG was allowed to bind to N2A cells and complexes
were eluted by the addition of a2,3SL at di¡erent concentrations as
described in Section 2. C: Elution of MAG binding partners with
a2,3SL after a⁄nity precipitations with Fc-MAGd1ÿ3 from
[3H]glucosamine-labelled N2A cell extract. SDS-PAGE of a⁄nity
precipitations of ligands for Fc-MAGd1ÿ3 from [3H]glucosamine-la-
belled N2A cell extract were performed as described in Section 2.
Lane 1: glycoproteins from a⁄nity precipitation with Fc-MAGd1ÿ3 ;
lane 2: glycoproteins eluted with 100 mM a2,3SL from Fc-MAG/
protein A beads after a⁄nity precipitation with Fc-MAGd1ÿ3 ; lane
3: glycoproteins which remained on the protein A beads after elu-
tion of ligands with a2,3SL; lane 4: glycoprotein eluted with PBS;
lane 5: glycoproteins which remained on protein A beads after elu-
tion of ligands with PBS. Molecular weights are shown on the left.
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GalL1,3GlcNAc and Neu5Aca2,3GalL1,4GlcNAc occurring
on N-linked glycans are recognised by MAG as well as Neu5-
Aca2,3GalL1,3GalNAc found on O-linked glycans [28],
although binding assays with derivatised erythrocytes had
suggested that MAG binds only to Neu5Aca2,3GalL1,3Gal-
NAc [23]. However, this is likely to be due to the three-fold
higher amount of Neu5Aca2,3GalL1,3GalNAc than that of
Neu5Aca2,3GalL1,3/4GlcNAc on these cells [32]. Further-
more, if Neu5Ac is replaced by high-a⁄nity Sia like Neu5-
ClAc or Neu5BrAc, Siaa2,3GalL1,3(4)GlcNAc glycans e⁄-
ciently support binding of MAG to resialylated erythrocytes,
indicating that these glycans can serve as ligand determinants
on cell surfaces [27].
The a⁄nity precipitation experiments with Fc-NCAM, Fc-
CD22 or Fc-Sn indicated that the isolation of potential coun-
ter-receptors is mediated by speci¢c binding to the extracellu-
lar domains of MAG and not to other parts of the Fc chi-
meras. NCAM is a neuronal cell adhesion molecule with a
substantial degree of sequence similarity to MAG [37]. The
broad smear precipitated by Fc-NCAM could be NCAM
which is expressed by N2A cells and is known to exhibit
homophilic interaction. CD22 is a member of the siglec family
but recognises a2,6-linked Sia, whereas MAG binds to a2,3-
linked Sia [3]. Therefore, it is unlikely that CD22 recognises
the same glycan structure as MAG but it could bind the same
glycoproteins if these contain a2,6-linked Sia. This seems not
to be the case, since proteins precipitated with Fc-CD22 ex-
hibit a distinct pattern di¡erent from that obtained with Fc-
MAG.
Sn, another member of the siglec family, has a similar gly-
can speci¢city as MAG [27,28]. Therefore, it could be ex-
pected that the same glycoproteins isolated as ligands for
MAG may also bind to Sn. However, the observation that
di¡erent proteins were precipitated by the Fc chimeras of
MAG and Sn indicates that additional structural features be-
sides Sia recognition are involved. This is supported by the
¢nding that modi¢cations of the Sia residue [27] and the
underlying glycan [28] contribute signi¢cantly to di¡erences
in the binding behaviour of MAG and Sn. Therefore, high
speci¢city could also be caused by yet unknown glycans oc-
curring on neuronal cells which are bound with high a⁄nity
by MAG but not by Sn. On the other hand, evidence has been
reported that Sia-dependent binding may be a primary dock-
ing mechanism and that an additional Sia-independent bind-
ing site exists on MAG [38]. Such additional binding could
also be a reason for the selective interaction of MAG ob-
served in this study.
Most, if not all, of the interaction of the isolated glycopro-
teins with MAG is Sia-dependent. This has been demon-
strated by sialidase treatment of N2A cells before lysis, the
inhibitory e¡ect of preincubating MAG with a2,3SL and by
the speci¢c elution of bound glycoproteins with a2,3SL. Only
small amounts of the precipitated proteins appear to bind to
MAG independent of Sia. This could be due to insu⁄cient
sialidase treatment or incomplete inhibition by a2,3SL. How-
ever, it cannot be excluded completely that the precipitation
of these proteins is mediated by Sia-independent interactions.
Since the MAG ligands are precipitated from a total cell
extract, it is possible that besides cell surface molecules gly-
coproteins from intracellular compartments were also iso-
lated. However, the fact that sialidase treatment of the intact
cells before lysis prevents precipitation of most of the counter-
receptors indicates that these proteins represent cell surface
molecules.
Our results show that MAG binds to N-glycans on glyco-
proteins of the neuronal cell line N2A in a Sia-dependent
manner. A method for the isolation of counter-receptors for
MAG from these cells has been developed and several glyco-
proteins have been isolated as potential ligands for MAG.
One important question will be whether these glycoproteins
also mediate the binding of MAG to neurones in vivo. To
answer this question it will be necessary to determine the
amino acid sequence of these proteins and to study their ex-
pression pattern during the development of the nervous sys-
tem.
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